| Authors: |
Shen M; Department of Molecular Biology, Princeton University, Princeton, New Jersey., Xie S; Department of Molecular Biology, Princeton University, Princeton, New Jersey.; Department of Cell Biology, Zhejiang University School of Medicine, Hangzhou, China.; The Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Cancer Center, Zhejiang University, Zhejiang, China., Rowicki M; Department of Molecular Biology, Princeton University, Princeton, New Jersey., Michel S; Secarna Pharmaceuticals GmbH & Co. KG, Planegg/Martinsried, Germany., Wei Y; Department of Molecular Biology, Princeton University, Princeton, New Jersey., Hang X; Department of Molecular Biology, Princeton University, Princeton, New Jersey., Wan L; Department of Molecular Biology, Princeton University, Princeton, New Jersey., Lu X; Department of Molecular Biology, Princeton University, Princeton, New Jersey., Yuan M; Department of Molecular Biology, Princeton University, Princeton, New Jersey., Jin JF; Firebrand Therapeutics, Princeton, New Jersey., Jaschinski F; Secarna Pharmaceuticals GmbH & Co. KG, Planegg/Martinsried, Germany., Zhou T; Cancer Center, Zhejiang University, Zhejiang, China.; Department of Cell Biology and Cancer Institute of the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Klar R; Secarna Pharmaceuticals GmbH & Co. KG, Planegg/Martinsried, Germany., Kang Y; Department of Molecular Biology, Princeton University, Princeton, New Jersey. ykang@princeton.edu.; Cancer Metabolism and Growth Program, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey. |
